Health law legal challenges: Date set for oral arguments in the 8th Circuit Court of Appeals

NewsGuard 100/100 Score

Politico Pro: Missouri Lawsuit To Get Appeals Hearing
Missouri's health reform lawsuit is heading for oral arguments in the 8th Circuit Court of Appeals. The 8th Circuit on Tuesday said oral arguments in the lawsuit, which challenges the individual mandate and the Medicaid expansion, will take place in St. Paul, Minn., during the week of Oct. 17. The suit was brought by Missouri Lt. Gov. Peter Kinder and is one of the most prominent in the second round of health reform lawsuits working its way up to the Supreme Court. Cases in the 4th, 6th and 11th circuit courts -; the first round of lawsuits -; are vying to be the first to be argued in Washington. The second round includes a challenge the D.C. Circuit of Appeals plans to hear on Sept. 23 (Haberkorn, 8/23).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Hearing loss linked to accelerated Alzheimer's progression via GDF1 pathway